Ads
related to: Eli Lilly and Company
Search results
Lilly Announces Details of Presentations at 2024 American Society of Clinical Oncology (ASCO) Annual...
FOX21 Colorado Springs· 4 hours agoEli Lilly and Company (NYSE: LLY) today announced that data from studies of Verzenio® (abemaciclib; a CDK4/6 inhibitor ...
Is Eli Lilly and Company the Largest Publicly Traded Healthcare Company?
Insider Monkey via Yahoo Finance· 1 day agoIn this article, we will be taking a look at is Eli Lilly and Company the largest publicly traded...
Eli Lilly Secures China Nod For Popular Weight Loss/Diabetes Drug Tirzepatide Why Is Eli Lilly Stock...
Benzinga· 2 days agoOn Tuesday, Eli Lilly And Company LLY announced that Chinese regulators have approved its diabetes...
Eli Lilly’s (LLY) diabetes injection Mufenda gets approval in China | Invezz
Invezz· 3 days agoEli Lilly and Company announced on Tuesday that the National Medical Products Administration (NMPA)...
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Zacks via Yahoo Finance· 7 days agoEli Lilly (LLY) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a...
Lilly (LLY) Hits Record High on Crohn's Disease Study Data
Zacks via Yahoo Finance· 1 day agoAktis will also be eligible to receive milestone payments of up to $1.1 billion and potential...
This Biotech Stock Is Poised For 80% Upside With Breakthrough In Obesity Drug Market, Says JPMorgan...
Benzinga· 2 days agoThe Structure Therapeutics GPCR stock has been identified as a potential winner in the obesity drug...
Eli Lilly's (LLY) Efsitora Matches Daily Insulins in A1C Control
Zacks· 7 days agoEli Lilly's (LLY) two phase III studies on its once-weekly insulin, efsitora alfa, meet their primary endpoint of non-inferior reduction in blood sugar levels compared with daily basal insulins.
More than one-half of patients with Crohn's disease treated with Lilly's mirikizumab achieved...
WTRF Wheeling· 3 days agoIn Eli Lilly and Company's (NYSE: LLY) pivotal Phase 3 VIVID-1 study, patients with moderately to severely active ...
Prostate Cancer Screening: What Does Your Patient Fear Most?
Medscape· 2 days agoDr Neil Skolnik distills available recommendations (including recent AUA guidance) to help...
